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INTRODUCTION
Colorectal cancer (CRC) is the fourth most common malignant neoplasm in the world, and also the most frequent in the digestive tract, presenting with high mortality rates -about half a million deaths per year 1, 2 . According to Andrade and Pereira, the adenocarcinoma responds for 90% of the CRC cases 1 .
The general incidence of cutaneous metastasis (CM) of gastrointestinal neoplasms is 5.3% 3 , and most of them appearing near the site of the primary tumor. Therefore, the CM of colonic tumors is usually in the pelvis and abdomen 4 . Frequently, CM means that the disease is at an advanced stage, with poor prognosis 5 . The mechanisms for the cutaneous metastases to occur are yet to be established. However, the speculation is that they can appear due to continu-ity through the peritoneal cavity or by the interconnected routes of the lymphatic and hematologic systems. The iatrogenic implantation during the surgical primary tumor resection is described as rare, but accounted for in the literature 5 . Considering the rare occurrence of cutaneous metastasis from colonic adenocarcinoma, an unusual case that took place at the Coloproctology Service in the Surgery Department of Santa Casa de São Paulo was described.
CASE REPORT
E.G.C.R., a 78-year-old female white patient, widower, was born in Portugal and had lived in São Paulo for 50 years. She weighed 46 kilos, her height was 1.58 m, body mass index of 18.47 and personal history of hypertension. She attended the service on October 23, 2009, complaining of changes in the bowel habit, mesogastric pain and anemia. Colonoscopy with biopsy and a computerized tomography of the abdomen and chest were performed, and the diagnosis was a right colon adenocarcinoma. On February 10, 2010, the patient underwent right hemicolectomy and resection of a tumor implant in the gastric wall. There were no signs of cutaneous metastasis.
The result of the anatomopathologic study of the hemicolectomy specimen came as a poorly differentiated adenocarcinoma of 12x10 cm, which invaded up to the pericolic fat (meso). Angiolymphatic invasion was present, and perineural neoplastic invasion was absent. Proximal and distal surgical margins were free of neoplastic compromise, and metastasis was present in 1 of the 10 dissected lymph nodes. The result also showed that the fiber conjunctive tissue of the gastric wall was compromised. Therefore, the patient was staged as pT3N1M1.
She was referred to chemotherapy with capecitabine, however, she only underwent two sections due to side-effect intolerance.
On October 5, 2010, the patient attended an outpatient clinic appointment and reported the appearance of a painful and fast-growing tumor on the left buttock ( Figure 1 ). At the physical examination, an approximately 3cm x 8cm tumor was observed. It was purple, hard, with central ulcerations, draining serosanguinolent secretion and located in the lower left buttock.
A pelvic nuclear magnetic resonance (NMR) was performed and showed a solid and large formation at the left gluteal region, adjacent to the intergluteal line, presenting contact with the gluteus maximus and the elevator of the anus, measuring 5.3x4.7x4.7 cm (Figure 2 ). An incisional biopsy of the tumor was also performed.
The anatomopathological study showed metastatic adenocarcinoma negative for CK7 and positive for CK20 in the skin of the gluteal region, with primary location most likely being the colorectum. Treatment with complete tumor exeresis was performed ( Figure 3) . The patient was discharged from the hospital in good conditions. Five months after the onset of metastasis in the gluteus, the patient evolved with no signs of recurrence.
DISCUSSION
The most common form of CRC dissemination is the lymphohematogenous pathway, affecting mainly the liver (75%), lungs (15%), bones (5%) and the central nervous system (5%). However, it can also be disseminated by contiguity to the peritoneum or intraabdominal organs 1 ; there are many reports of metastasis to unusual locations.
Balsamo and Formiga described colorectal adenocarcinoma metastasis to the jaws 6 , while Contu et al. described colonic metastasis to endotracheal and endobronchial sites after the primary treatment 7 . Torosian et al. described colorectal tumor metastasis to the thigh skeletal muscles 8 . Costa also reported vaginal metastasis, isolated from the colon cancer, which is extremely rare 9 . The reports of CRC metastases to the skin are unusual and poorly described in literature 4, 7 . The general incidence of cutaneous metastasis is 5.3% 3 , and most occur near the site of the primary tumor 4 . Therefore, the metastasis of the colonic tumor is usually to the pelvis and abdomen 4 . Another study with 724 patients showed that the neoplasms that mostly cause cutaneous metastases in women are: breast (69%), colon (9%), melanoma (5%), ovarian (4%) and pulmonary (4%) 4 . Among men, these metastases come from the lungs (24%), the colon (19%), melanoma (13%) and the oral cavity (12%) 4 . A retrospective study by Lookingbill demonstrated that skin involvement caused by colorectal tumor at the time of diagnosis was present in 0.05% of the patients with cutaneous metastasis. This study included 7,316 patients with cancer, and found 367 with skin involvement (5%) 10 . In a sample of 413 patients with metastatic colorectal cancer, 18 (4.4%) presented with cutaneous metastases, and most were in the abdominal incision 5, 10 . As described in literature, the adenocarcinoma metastasis to the skin is uncommon, and usually happens near the primary site due to continuity or surgical implant 10 . However, this case reports isolated metastasis from the right colon to the skin, with no signs of the dissemination pathway. Also, the access pathway of the primary tumor resection was distant from the place of metastasis implantation.
The mechanisms for the cutaneous metastases to occur are yet to be estabished. However, the speculation is that they may occur due to continuity through the peritoneal cavity or by the interconnected routes of the lymphatic and hematologic systems. The iatrogenic implantation during the surgical primary tumor resection is rare, but considered in literature 4 . With the current knowledge on molecular biology, there is not only the possibility of passive dissemination pathway, known as "tumor embolization", but also an easier way through the processes of angiogenesis and angiolymphatic growth factors that help to increase the total surface of blood vessels for tumor cell invasion. Following the blood vessel invasion, tumor cells that resist to the mechanic stress of circulation and to the immune system "colonize" the subcutaneous tissues until they acquire the necessary angiogenic properties and a favorable microenvironment to leave the state of "numbness" The estimated survival rate is short, from 1 to 34 months, after the diagnosis of cutaneous metastasis. The mean of 18 months has been described for patients with cutaneous metastasis from colorectal tumor 5, 10 . The cutaneous metastasis from a visceral neoplasm predicts the systemic compromise of the tumor with multiple metastases and poor prognosis 5, 10, 11 . In our case, no evidence of hepatic, lung or bone compromise has been found, and these are common metastatic dissemination pathways of colorectal neoplasm.
Both in the primary tumor and the metastasis, the patient was submitted to the treatment recommended in literature, that is, the surgical tumor resection. Chemotherapy was indicated due to the lymph node involvement observed in the right colon tumor resection, and due to the presence of resected neoplastic implant in the gastric wall; however, the patient refused to take the treatment because of the side effects.
Regarding the diagnosis of metastatic colorectal cancer to the skin, the treatment can be based on the relief of symptoms and comfort for the patient, but the local treatment, with radiotherapy or surgery, should be evaluated.
CONCLUSION
Even though the presence of cutaneous metastasis from colorectal cancer is associated with poor prognosis, the surgical resection of these metastases is a good treatment option when associated with low morbidity and improvement in the quality of life.
